Select a Region North America

M&A and BD&L Outlook and Perspectives on Commercial Due Diligence

In this webinar, industry leaders Faruk Abdullah, James Stephanou, Jakub Pijewski, PhD, and Yao Zhang, PhD, delve into the dynamic world of M&A, BD&L, and Commercial Due Diligence (CDD) in the pharmaceutical and biotech sectors.

Gain valuable insights into:

  • Current perspectives on deal-making trends
  • The heightened importance of CDD
  • Best practices and risk mitigation techniques for optimizing CDD efforts

Complete the form below to view the full webinar recording.

Author
Faruk Abdullah
President, Professional Services and Chief Business Officer

Faruk is a life sciences professional with extensive experience addressing a broad range of strategic issues, including corporate development, portfolio planning, and launch excellence.

James Stephanou
Senior Partner

James (Jim) Stephanou, Senior Partner, EVERSANA Management Consulting, is a healthcare and life sciences professional who has spent the last 18+ years of his career helping clients address a broad range of strategic issues,…